Mentioned On
Episode Mentions
Freakonomics Radio · Feb 20, 2026
664. Are Thousands of Medical Cures Hiding in Plain Sight?
“Developed next-generation pneumococcal vaccine with more strains under advanced market commitment”
Drug Repurposing EconomicsAdvanced Market CommitmentsFDA Regulatory Pathways
View Analysis
The Peter Attia Drive · Jul 21, 2025
#357 ‒ A new era of longevity science: models of aging, human trials of rapamycin, biological clocks, promising compounds, and lifestyle interventions | Brian Kennedy, Ph.D.
“Acquired resveratrol company around 2006-2007; failed to develop effective longevity drug, slowing field investment”
mTOR signaling and rapamycin dosing strategiesBiological aging clocks and mortality predictionAlpha-ketoglutarate supplementation and lifespan extension
View Analysis